| |
|
|
| Name: |
BAKER BROS ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10021 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
100 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BGNE |
Beigene Ltd |
1 |
- |
$313.67 |
$2,129,987,000 |
8,799,053 |
20.66% |
-264,851,000 |
0 |
9.709 |
N/A |
|
|
INCY |
Incyte Corp |
2 |
- |
$85.04 |
$2,093,617,000 |
30,743,275 |
20.31% |
232,313,000 |
3,322 |
14.038 |
Biotechnology |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
3 |
- |
$25.74 |
$925,282,000 |
42,896,690 |
8.98% |
213,080,000 |
18,774 |
23.827 |
Biotechnology |
|
|
INSM |
Insmed Inc |
4 |
- |
$131.88 |
$776,226,000 |
7,712,900 |
7.53% |
365,738,000 |
2,332,274 |
3.72 |
Biotechnology |
|
|
SMMT |
Summit Therapeutics Inc |
5 |
- |
$26.20 |
$717,625,000 |
33,722,974 |
6.96% |
246,469,000 |
9,298,109 |
4.812 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
6 |
- |
$414.68 |
$598,022,000 |
1,976,018 |
5.8% |
-56,021,000 |
1,428 |
7.686 |
Diagnostic Substances |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
7 |
- |
$103.27 |
$354,147,000 |
5,604,483 |
3.44% |
57,278,000 |
0 |
7.901 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
8 |
- |
$37.01 |
$344,537,000 |
9,364,972 |
3.34% |
63,886,000 |
1,428,000 |
4.669 |
N/A |
|
|
KYMR |
Kymera Therapeutics, Inc. |
9 |
- |
$0.00 |
$290,268,000 |
6,651,429 |
2.82% |
126,159,000 |
655,500 |
7.833 |
N/A |
|
|
ALKS |
Alkermes Plc |
10 |
- |
$29.75 |
$183,407,000 |
6,410,603 |
1.78% |
35,369,000 |
1,927,318 |
3.49 |
Drug Delivery |
|
|
REPL |
Replimune Group Inc |
11 |
- |
$5.67 |
$102,611,000 |
11,045,336 |
1% |
-5,081,000 |
0 |
12.832 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
12 |
- |
$29.78 |
$100,815,000 |
2,772,692 |
0.98% |
43,744,000 |
1,196,578 |
3.011 |
Restaurants |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
13 |
- |
$14.85 |
$95,781,000 |
7,305,940 |
0.93% |
-39,650,000 |
1,150,000 |
5.842 |
N/A |
|
|
ABCL |
Abcellera Biologics Inc. |
14 |
- |
$0.00 |
$94,413,000 |
27,525,640 |
0.92% |
33,031,000 |
0 |
10.225 |
N/A |
|
|
IMVT |
Immunovant Inc |
15 |
- |
$0.00 |
$87,326,000 |
5,457,881 |
0.85% |
-5,949,000 |
0 |
3.213 |
N/A |
|
|
GRAL |
Grail, Llc |
16 |
- |
$34.24 |
$83,821,000 |
1,630,125 |
0.81% |
42,188,000 |
0 |
5.242 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
17 |
- |
$33.75 |
$78,159,000 |
2,824,669 |
0.76% |
15,564,000 |
6,346 |
6.983 |
N/A |
|
|
BCYC |
Bicycle Therapeutics Ltd |
18 |
- |
$0.00 |
$75,653,000 |
10,885,357 |
0.73% |
-16,764,000 |
0 |
15.778 |
N/A |
|
|
IMCR |
Immunocore Holdings Adr |
19 |
- |
$32.93 |
$72,885,000 |
2,322,656 |
0.71% |
3,972,000 |
0 |
4.645 |
N/A |
|
|
CELC |
Celcuity Inc. |
20 |
- |
$52.42 |
$72,763,000 |
5,450,445 |
0.71% |
29,717,000 |
1,192,710 |
14.719 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
21 |
- |
$10.20 |
$64,568,000 |
17,310,490 |
0.63% |
16,012,000 |
0 |
38.64 |
N/A |
|
|
IMTX |
Immatics N.V |
22 |
- |
$5.69 |
$54,709,000 |
10,168,901 |
0.53% |
21,895,000 |
2,893,071 |
9.862 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
23 |
- |
$19.56 |
$52,594,000 |
4,633,838 |
0.51% |
21,779,000 |
0 |
7.044 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
24 |
- |
$15.49 |
$52,206,000 |
3,731,695 |
0.51% |
1,474,000 |
0 |
2.61 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
25 |
- |
$19.61 |
$52,032,000 |
2,508,767 |
0.5% |
45,773,000 |
2,147,202 |
3.982 |
N/A |
|
|
IDYA |
Ideaya Biosciences, Inc. |
26 |
- |
$0.00 |
$44,536,000 |
2,118,728 |
0.43% |
27,138,000 |
1,056,605 |
2.173 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
27 |
- |
$0.00 |
$44,217,000 |
3,882,125 |
0.43% |
-1,903,000 |
0 |
4.371 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
28 |
- |
$11.92 |
$42,463,000 |
3,767,773 |
0.41% |
4,446,000 |
0 |
0.544 |
N/A |
|
|
BNTX |
Biontech Se Adr |
29 |
- |
$0.00 |
$39,279,000 |
368,923 |
0.38% |
35,178,000 |
323,892 |
0.155 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
30 |
- |
$0.00 |
$32,698,000 |
4,865,819 |
0.32% |
-11,289,000 |
0 |
15.59 |
N/A |
|
|
MRUS |
Merus Nv |
31 |
- |
$67.49 |
$30,212,000 |
574,377 |
0.29% |
20,805,000 |
350,877 |
0.802 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
32 |
- |
$0.00 |
$28,993,000 |
689,488 |
0.28% |
16,438,000 |
357,955 |
1.316 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
33 |
- |
$10.52 |
$25,098,000 |
2,675,674 |
0.24% |
20,518,000 |
2,031,558 |
2.634 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
34 |
New |
$19.23 |
$24,387,000 |
1,744,406 |
0.24% |
24,387,000 |
1,744,406 |
1.846 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
35 |
- |
$0.00 |
$22,172,000 |
4,916,095 |
0.22% |
-639,000 |
0 |
8.011 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
36 |
- |
$0.00 |
$21,171,000 |
223,843 |
0.21% |
6,959,000 |
0 |
0.277 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
37 |
- |
$0.00 |
$20,835,000 |
640,885 |
0.2% |
-3,365,000 |
0 |
0.05 |
N/A |
|
|
ARGX |
Argenx Se |
38 |
- |
$660.00 |
$20,814,000 |
37,760 |
0.2% |
-25,209,000 |
-40,000 |
0.08 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
39 |
- |
$0.00 |
$18,996,000 |
1,691,530 |
0.18% |
11,266,000 |
0 |
1.898 |
N/A |
|
|
CERS |
Cerus Corp |
40 |
- |
$1.27 |
$18,166,000 |
12,883,844 |
0.18% |
-8,732,000 |
-6,467,243 |
7.708 |
Biotechnology |
|
|
IRON |
Disc Medicine, Inc |
41 |
- |
$60.35 |
$17,850,000 |
337,050 |
0.17% |
14,025,000 |
260,000 |
0.967 |
N/A |
|
|
AKRO |
Akero Therapeutics, Inc. |
42 |
- |
$0.00 |
$17,322,000 |
324,630 |
0.17% |
-4,890,000 |
-224,083 |
0.358 |
N/A |
|
|
BPMC |
Blueprint Medicines Corp |
43 |
New |
$129.46 |
$16,091,000 |
125,538 |
0.16% |
16,091,000 |
125,538 |
0.169 |
N/A |
|
|
SERA |
Sera Prognostics, Inc. |
44 |
- |
$2.38 |
$15,230,000 |
5,498,170 |
0.15% |
-5,003,000 |
0 |
18.772 |
N/A |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
45 |
New |
$21.33 |
$14,839,000 |
939,174 |
0.14% |
14,839,000 |
939,174 |
0.68 |
Business Services |
|
|
NGNE |
Neurogene |
46 |
- |
$3.68 |
$14,826,000 |
991,691 |
0.14% |
-2,577,000 |
-494,509 |
2.367 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
47 |
New |
$0.70 |
$14,713,000 |
789,759 |
0.14% |
14,713,000 |
789,759 |
2.009 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
48 |
- |
$22.46 |
$13,540,000 |
665,370 |
0.13% |
9,045,000 |
417,726 |
0.902 |
Diagnostic Substances |
|
|
DBVT |
DBV Technologies SA |
49 |
- |
$0.61 |
$13,387,000 |
1,461,425 |
0.13% |
3,420,000 |
0 |
5.813 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
50 |
- |
$0.00 |
$11,588,000 |
370,208 |
0.11% |
-68,000 |
22,800 |
0.431 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
51 |
New |
$66.37 |
$11,070,000 |
227,272 |
0.11% |
11,070,000 |
227,272 |
1.752 |
N/A |
|
|
ACLX |
Arcellx, Inc. |
52 |
New |
$0.00 |
$10,985,000 |
166,825 |
0.11% |
10,985,000 |
166,825 |
0.258 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
53 |
New |
$0.00 |
$10,982,000 |
143,937 |
0.11% |
10,982,000 |
143,937 |
0.196 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
54 |
New |
$0.60 |
$9,382,000 |
626,703 |
0.09% |
9,382,000 |
626,703 |
0.976 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
55 |
- |
$0.00 |
$9,251,000 |
4,004,756 |
0.09% |
3,684,000 |
0 |
2.142 |
N/A |
|
|
PRLD |
Prelude Therapeutics Inc |
56 |
- |
$0.00 |
$8,194,000 |
10,123,824 |
0.08% |
419,000 |
0 |
23.167 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
57 |
New |
$30.92 |
$8,053,000 |
280,000 |
0.08% |
8,053,000 |
280,000 |
0.262 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
58 |
New |
$0.00 |
$7,909,000 |
3,484,226 |
0.08% |
7,909,000 |
3,484,226 |
5.347 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
59 |
- |
$7.11 |
$7,262,000 |
952,996 |
0.07% |
4,155,000 |
0 |
4.462 |
N/A |
|
|
SION |
Sionna Therapeutics, Inc. |
60 |
- |
$0.00 |
$6,940,000 |
400,000 |
0.07% |
2,756,000 |
0 |
0.907 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
61 |
New |
$38.80 |
$6,315,000 |
189,866 |
0.06% |
6,315,000 |
189,866 |
0.275 |
N/A |
|
|
RAPP |
Rapport Therapeutics, Inc. |
62 |
New |
$14.77 |
$6,255,000 |
550,090 |
0.06% |
6,255,000 |
550,090 |
1.432 |
N/A |
|
|
SKYE |
Skye Bioscience Inc |
63 |
- |
$3.29 |
$6,064,000 |
1,450,638 |
0.06% |
3,757,000 |
0 |
5.168 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
64 |
- |
$0.00 |
$5,772,000 |
1,712,882 |
0.06% |
-959,000 |
-30,843 |
3.08 |
N/A |
|
|
KALA |
Kala Pharmaceuticals, Inc. |
65 |
- |
$9.21 |
$5,721,000 |
1,201,894 |
0.06% |
-1,166,000 |
0 |
26.072 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
66 |
- |
$0.00 |
$5,544,000 |
2,030,949 |
0.05% |
2,132,000 |
0 |
1.083 |
N/A |
|
|
XNCR |
Xencor Inc |
67 |
- |
$8.41 |
$5,270,000 |
670,431 |
0.05% |
-1,863,000 |
0 |
0.745 |
Biotechnology |
|
|
ALMS |
Alumis Inc. |
68 |
- |
$4.84 |
$4,688,000 |
1,562,500 |
0.05% |
-4,906,000 |
0 |
3.309 |
N/A |
|
|
IGMS |
Igm Biosciences, Inc. |
69 |
- |
$0.00 |
$4,588,000 |
4,096,210 |
0.04% |
-122,000 |
953 |
16.913 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
70 |
- |
$0.00 |
$4,038,000 |
2,784,792 |
0.04% |
195,000 |
0 |
6.394 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
71 |
- |
$3.69 |
$4,014,000 |
1,160,117 |
0.04% |
974,000 |
0 |
0.695 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
72 |
- |
$1.15 |
$2,783,000 |
2,485,018 |
0.03% |
209,000 |
-773,384 |
1.498 |
Biotechnology |
|
|
VIR |
Vir Biotechnology, Inc. |
73 |
- |
$0.00 |
$2,734,000 |
542,539 |
0.03% |
-782,000 |
0 |
0.426 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
74 |
- |
$0.00 |
$2,304,000 |
114,833 |
0.02% |
44,000 |
0 |
0.229 |
N/A |
|
|
WVE |
Wave Life Sciences Ltd. |
75 |
- |
$10.15 |
$2,236,000 |
344,063 |
0.02% |
-544,000 |
0 |
0.223 |
N/A |
|
|
TECX |
Tectonic Therapeutic Inc |
76 |
- |
$26.18 |
$1,987,000 |
100,000 |
0.02% |
216,000 |
0 |
0.679 |
N/A |
|
|
CADL |
Candel Therapeutics, Inc. |
77 |
- |
$0.00 |
$1,797,000 |
355,112 |
0.02% |
-11,973,000 |
-2,082,077 |
1.238 |
N/A |
|
|
TARA |
Protara Therapeutics, Inc |
78 |
- |
$3.11 |
$1,627,000 |
536,832 |
0.02% |
-660,000 |
0 |
1.391 |
N/A |
|
|
VTVT |
Vtv Therapeutics Inc. |
79 |
- |
$0.35 |
$1,460,000 |
97,314 |
0.01% |
-225,000 |
0 |
0.218 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
80 |
- |
$3.64 |
$1,353,000 |
552,079 |
0.01% |
-5,965,000 |
-545,000 |
0.488 |
N/A |
|
|
CTNM |
Contineum Therapeutics, Inc. |
81 |
- |
$9.94 |
$1,241,000 |
312,500 |
0.01% |
-940,000 |
0 |
1.215 |
N/A |
|
|
HOOK |
Hookipa Pharma Inc. |
82 |
- |
$0.87 |
$1,020,000 |
812,814 |
0.01% |
142,000 |
0 |
1.598 |
N/A |
|
|
NMRA |
Neumora Therapeutics, Inc. |
83 |
- |
$1.62 |
$759,000 |
1,034,600 |
0.01% |
-276,000 |
0 |
0.678 |
N/A |
|
|
GBIO |
Generation Bio Co. |
84 |
- |
$0.00 |
$623,000 |
1,944,945 |
0.01% |
-165,000 |
0 |
3.273 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
85 |
- |
$0.00 |
$599,000 |
83,055 |
0.01% |
-86,000 |
0 |
0.115 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
86 |
- |
$0.00 |
$102,000 |
10,607 |
0% |
3,000 |
0 |
0.019 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
87 |
- |
$1.36 |
$27,000 |
22,809 |
0% |
-19,000 |
0 |
0.074 |
N/A |
|
|
SRZNW |
Surrozen Equity Warrant Exp... |
88 |
- |
$0.00 |
$15,000 |
833,333 |
0% |
-10,000 |
0 |
9.259 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
98 |
Closed |
$3.55 |
$0 |
0 |
0% |
-2,047,000 |
-1,028,466 |
0 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
96 |
Closed |
$12.58 |
$0 |
0 |
0% |
-7,030,000 |
-672,096 |
0 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
92 |
Closed |
$54.32 |
$0 |
0 |
0% |
-22,259,000 |
-654,099 |
0 |
N/A |
|
|
LPTX |
Leap Therapeutics, Inc. |
97 |
Closed |
$0.30 |
$0 |
0 |
0% |
-123,000 |
-404,744 |
0 |
N/A |
|
|
RGLS |
Regulus Therapeutics Inc. |
90 |
Closed |
$8.16 |
$0 |
0 |
0% |
-4,715,000 |
-2,694,044 |
0 |
Biotechnology |
|
|
CMPX |
Compass Therapeutics Ord Shs |
91 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,040,000 |
-547,498 |
0 |
N/A |
|
|
OPT |
Opthea Ltd |
89 |
- |
$3.41 |
$0 |
2,087,320 |
0% |
0 |
0 |
4.945 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
95 |
Closed |
$42.69 |
$0 |
0 |
0% |
-10,798,000 |
-357,915 |
0 |
Drug Manufacturers - ... |
|
|
BCAX |
Bicara Therapeutics Inc. |
100 |
Closed |
$11.84 |
$0 |
0 |
0% |
-10,858,000 |
-833,333 |
0 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
94 |
Closed |
$0.00 |
$0 |
0 |
0% |
-115,000 |
-241,684 |
0 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
99 |
Closed |
$0.00 |
$0 |
0 |
0% |
-12,338,000 |
-2,497,526 |
0 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
93 |
Closed |
$0.00 |
$0 |
0 |
0% |
-17,647,000 |
-1,227,178 |
0 |
N/A |
|
